Wednesday, April 04, 2012

Abbott Hep Drug 93 Pct. Effective in Ph2 Study - Apr. 4, 2012

Having trouble viewing this email? View in Browser.
ClinicaSpace Focus
   Wednesday, April 04, 2012 Advertising Information
subscriptions careernetwork news hotbeds careerfairs
Facebook  |  Linked In  |  Twitter  |  RSS  |  Subscribe

TOP SPONSOR

Crown Bioscience Inc. leads the field in providing unique translational platforms and cost effective drug discovery solutions for its biotech and pharmaceutical partners in dedicated therapeutic areas: Oncology and Metabolic Disease. Our multi-disciplinary team of experts, headquartered in the heart of Silicon Valley, with wholly own research facilities in Kanapolis, Beijing (China), and Taicang (China)., provides an integrated service solution from your idea to an enabling IND, including: preclinical, translational and clinical capabilities. CrownBio offers a truly integrated approach to undertaking complete drug discovery programs as well as hit identification, hit-to-lead, and lead optimization projects.

To learn more about our unique portfolio and breadth of services, visit www.crownbio.com or call us at 603-686-9330.
HeadHtml
•  Abbott Laboratories (ABT) Hep Drug 93 Pct. Effective in Phase 2 Study More...
•  UCB, Inc. (UCBJF.PK) and Amgen (AMGN) Initiate Sclerostin Antibody Phase 3 Program in Patients With Postmenopausal Osteoporosis More...
•  Peregrine Pharmaceuticals, Inc. (PPHM) Cites Clinical Data to Highlight Potential of Bavituximab More...
•  GTX Corp Submits Clinical Hold Complete Response Letter to FDA For Its Planned Phase II Clinical Study Of Capesaris® For Secondary Hormonal Therapy of Advanced Prostate Cancer More...
•  Array BioPharma, Inc. (ARRY) Release: Encouraging Selumetinib Results Announced for Phase 2 Trial in Ovarian Cancer More...
More Phase III News
More Phase II News
More Phase I News
More Pre-Clinical News
More Post-Approval News
Featured Free Resource

Building Novel Applications with Pipeline Pilot to Drive Next Generation Sequencing

This case study shows how scientists are streamlining the process of analyses of DNA sequence information. Enabled by new DNA sequencing technologies, many more scientists and informaticians are interrogating larger and more complex data set.

Request Now!
HeadHtml
•  Women's Height Linked to Ovarian Cancer, Oxford University Study More...
•  Antibiotics Linked to Retinal Detachment Risk, University of British Columbia Study More...
•  Coffee Drinking in Pregnancy Won't Lead to Sleepless Baby, Federal University of Pelotas Study More...
•  Bilingual Children Switch Tasks Faster Than Speakers of a Single Language, University of Toronto Study More...
•  Caffeine and Exercise: a Protective Mix Against Skin Cancer, Rutgers Ernest Mario School of Pharmacy Study More...
More General Clinical Research News
Events

2012 Workshop on Protein Aggregation and Immunogenicity
July 9-12, 2012
Early Registration: $695 - $1,395

Aggregation of therapeutic proteins can occur during bioprocessing, shipping, storage and even delivery to the patient. Understanding of the roles of aggregates in immunogenicity of therapeutic protein products is critical. Such immune responses can have serious consequences for patients. Also, immunogenicity can be major stumbling blocks to product development and has even plagued licensed protein therapeutics. To increase understanding of the impact of protein aggregation on immunogenicity, the Workshop will focus on five central areas:

1) clinical aspects of immunogenicity to therapeutic proteins;
2) utility of animal models and in vitro cell assays for assessing immunogenicity of aggregates and particles;
3) causes and control of aggregates and particles in formulations;
4) causes and control of aggregates and particles during processing; and
5) insights and challenges with analytical methods.

Please note: The early registration fee expires May 1, 2012, and includes a buffet for breakfast and lunch each day, opening and closing receptions, and a workshop notebook.

To register and view the schedule of speakers by industry leader's visit our website.
Latest Market Insight

Optimizing Clinical Trials Through IT

• Examine the trends shaping clinical trials.
• Learn how social media are being used in patient recruitment.
• Analyse the potential of electronic health record data in clinical development.

Click Here for More Information.
Tower: Facebook
Top Jobs
BioCapital (Wilmington, Delaware)

AstraZeneca Pharmaceuticals LP
Statistical Science Director, Clinical Science
The main roles undertaken by the Statistical Science Director are Global Product Statistician (GPS), Statistical Expert or Delivery Team Leader. Statistical Science Directors provide highly experienced strategic, statistical support and leadership to product teams, specialised areas (e.g. patient safety, clinical pharmacology alliance, personalised healthcare), and the Statistics & Programming Department, in the creation of clinical development programmes to maximise the market potential of AstraZeneca products

Biotech Beach (San Diego, California)

Ceregene, Inc.
Clinical Operations Associate
Responsible for various in-house activities related to clinical data managed by a contract research organization (CRO). Initiates manual queries of CRO and Ceregene databases and reviews for correct data values. Investigates and resolves incorrect data values with CRO contact.

Biotech Bay (Santa Rosa, California)

On Assignment Clinical Research
Clinical Research Specialist
Works closely with the study manager to satisfy applicable clinical and regulatory requirements and internal requirements for clinical studies. This role focuses on assigned areas of clinical study management and provides support for clinical deliverables required in the Product Commercialization Process This role may perform some site training and co-monitoring.

Rocky Bio (Tucson, Arizona)

Ventana Medical Systems, Inc.
Clinical Data Specialist
Supervises data capture in clinical studies and implements tools to improve clinical data management, including quality initiatives to ensure that high quality clinical data sets are created to support US Food and Drug Administration (FDA) submissions for Ventana products.

Pharm Country (Bridgewater, New Jersey)

Omega Management Group
Clinical Quality Control Manager
Will manage the QC department in regards to clinical and regulatory documentation QC. In addition s/he will be responsible for the managing of the clinical departments SOPs in accordance with GCP guidelines. This includes training of responsible individuals within and across departments. In addition s/he will maintain and support QC audits of clinical Trial Master Files.

• Get Noticed! Add your resume to the BioSpace Career Center!
• See more than 5,000 job postings in the BioSpace Career Center!


Biotech Beach

Biotech Beach Career Fair

Job seekers can spend a day with HR representatives and Hiring Managers from top biotech, pharma, medical device and diagnostics companies in the Southern California area.

Candidates with a 4-year degree in the life sciences and a minimum of 2-years of industry related experience are invited to attend. (Equivalent work experience may be considered in lieu of a four-year college degree. PhD and Postdoc candidates welcome.)

Exhibiting companies are recruiting for positions in areas such as: QA/QC, clinical research, engineering, manufacturing, biostatistics, clinical data management, chemistry, regulatory affairs, and research.

Job seekers may register here.

Biotech Beach Career Fair, La Jolla, CA April 17, 2012
BioCapital Career Fair, Bethesda, MD April 25, 2012
Pharm Country Career Fair, King Of Prussia, PA May 1, 2012
BioNC Career Fair, Durham, NC May 2, 2012
Biotech Bay Career Fair, Burlingame, CA May 29, 2012

More information about BioSpace's Career Fairs

BioSpace White Paper
Biotech Career Fairs For Job Seekers 101: Control Your Experience
By June Salvati, BioSpace Director of Events and Corporate Services
HeadHtml
•  Lixte Biotechnology Receives US Patent for Its Proprietary Histone Deacetylase Inhibitor More...
•  Athersys, Inc. Receives U.S. Patent Covering the Suppression of Graft-versus-Host Disease Associated With Hematopoietic Stem Cell Transplantation With Adult Stem Cells More...
•  Applied BioCode, Inc. Granted Additional Patent for Barcoded Magnetic Beads Used for Multiplex MDx Assays More...
•  XenoPort, Inc. (XNPT) Awarded U.S. Patent Directed to Composition and Formulations of XP23829, a Novel Fumarate Analog for the Potential Treatment of Relapsing-Remitting Multiple Sclerosis and Psoriasis More...
More Patent News
HeadHtml
•  FDA Finds More Fake Batches of Roche (RHHBY)'s Avastin Cancer Drug in U.S. More...
More Drug Product News
Feature

Hot Company

Eli Lilly and Company
Lilly Corporate Center
Indianapolis, Indiana 46285 U.S.A.
Phone: 317-276-2000

Lilly makes medicines that help people live longer, healthier, more active lives. We were founded by Eli Lilly in 1876, and are now the 10th largest pharmaceutical company in the world. We have steadfastly remained independent, but not isolated. Across the globe, Lilly has developed productive alliances and partnerships that advance our capacity to develop innovative medicines at lower costs.

More Company Profiles
Contact Us

Post Your: News | Jobs | Company Profile | Event | Advertising / Sponsorship

ClinicaSpace
6465 South Greenwood Plaza, Suite 400
Centennial, Colorado 80111 U.S.A.
Phone: 877-277-7585
Fax: 800-595-2929
ClinicaSpace
90 New Montgomery Street, Suite 414
San Francisco, California 94105 U.S.A.
Phone: 877-277-7585
Fax: 415-576-9217

Send questions and comments to the ClinicaSpace News Beat Team.

Editor & Publisher: Rosemary Do
Editorial & Production Staff: Lana Ho, Maysa Darwish, Tammy Liu, Michelle Wong

ClinicaSpace.com - Clinical Trials. Clinical Research. Community.
Legal Notice
• ClinicaSpace is a registered trademark of BioSpace, Inc.
• Please distribute this e-cast freely.
• Credit any excerpts as follows:
Copyright 2012 ClinicaSpace http://www.clinicaspace.com
• While BioSpace and its agents used their best efforts in collecting and preparing the information published herein, we do not assume, and hereby disclaim, any liability for any loss or damage caused by errors or omissions, whether such errors or omissions resulted from negligence, accident or other causes.
Subscribe/Unsubscribe
If someone forwarded this news to you and you'd like to receive your own copy FREE of charge, simply Subscribe here.

Safely unsubscribe from ClinicaSpace.com e-mail at any time by managing your account here.
 


No comments: